Patents by Inventor Edward H. Wang

Edward H. Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENERATING EARLY HINTS INFORMATIONAL RESPONSES AT AN INTERMEDIARY SERVER
    Publication number: 20230088115
    Abstract: An intermediary server receives a request from a client that identifies an asset that is handled by an origin server. The intermediary server generates an informational response that includes one or more link header fields that reference one or more pieces of content respectively that are predicted by the intermediary server to be linked within a final response for the asset. The intermediary server transmits the generated informational response to the client prior to a final response for the request. The intermediary server transmits the request to the origin server and receives a final response to the request. The intermediary server transmits the final response to the request to the client.
    Type: Application
    Filed: May 2, 2022
    Publication date: March 23, 2023
    Inventors: Alex Krivit, Rustam Xing Lalkaka, Samantha Aki Shugaeva, Edward H. Wang, Yuchen Wu
  • Generating early hints informational responses at an intermediary server
    Patent number: 11323537
    Abstract: An intermediary server determines, for an asset handled by an origin server, piece(s) of content for inclusion in link header field(s) in an informational response that signifies that the piece(s) of content are predicted to be linked within a final response for the asset. The intermediary server generates an informational response that includes the link header field(s) and responds to a request from a client with the informational response. The intermediary server transmits the request to the origin server. The intermediary server receives the final response to the request from the origin server, and transmits the final response to the client.
    Type: Grant
    Filed: September 15, 2021
    Date of Patent: May 3, 2022
    Assignee: CLOUDFLARE, INC.
    Inventors: Alex Krivit, Rustam Xing Lalkaka, Samantha Aki Shugaeva, Edward H. Wang, Yuchen Wu
  • Kinase inhibitors
    Patent number: 7692005
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Grant
    Filed: July 12, 2006
    Date of Patent: April 6, 2010
    Assignee: Allergan, Inc.
    Inventors: Julie A. Wurster, Edward H. Wang, Richard C. Yee
  • 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
    Patent number: 7414054
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Grant
    Filed: November 15, 2005
    Date of Patent: August 19, 2008
    Assignee: Allergan, Inc.
    Inventors: Steven W. Andrews, Julie A. Wurster, Edward H. Wang, Thomas Malone
  • (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
    Patent number: 7060844
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Grant
    Filed: April 1, 2003
    Date of Patent: June 13, 2006
    Assignee: Allergan, Inc.
    Inventors: Steven W. Andrews, Xialing Guo, Zhen Zhu, Clarence E. Hull, III, Julie A. Wurster, Shimiao Wang, Edward H. Wang, Thomas Malone
  • 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
    Patent number: 7015220
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Grant
    Filed: February 20, 2004
    Date of Patent: March 21, 2006
    Assignee: Allergan, Inc.
    Inventors: Steven W. Andrews, Julie A. Wurster, Edward H. Wang, Thomas Malone
  • 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
    Publication number: 20040198720
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Application
    Filed: February 20, 2004
    Publication date: October 7, 2004
    Inventors: Steven W. Andrews, Julie A. Wurster, Edward H. Wang, Thomas Malone
  • 3-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
    Patent number: 6765012
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Grant
    Filed: September 27, 2002
    Date of Patent: July 20, 2004
    Assignee: Allergan, Inc.
    Inventors: Steven W. Andrews, Julie A. Wurster, Edward H. Wang, Thomas Malone
  • (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
    Publication number: 20040019098
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Application
    Filed: April 1, 2003
    Publication date: January 29, 2004
    Applicant: Allergan, Inc.
    Inventors: Steven W. Andrews, Xialing Guo, Zhen Zhu, Clarence E. Hull, Julie A. Wurster, Shimiao Wang, Edward H. Wang, Thomas Malone
  • 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
    Publication number: 20030199478
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Application
    Filed: September 27, 2002
    Publication date: October 23, 2003
    Inventors: Steven W. Andrews, Julie A. Wurster, Edward H. Wang, Thomas Malone
  • (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
    Patent number: 6541504
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: April 1, 2003
    Assignee: Allergan Sales, LLC
    Inventors: Steven W. Andrews, Julie A. Wurster, Clarence E. Hull, III, Edward H. Wang, Thomas Malone, Xialing Guo, Zhen Zhu